HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Obesity-induced endothelial dysfunction is prevented by deficiency of P-selectin glycoprotein ligand-1.

Abstract
Endothelial dysfunction precedes atherosclerosis and represents an important link between obesity and cardiovascular events. Strategies designed to prevent endothelial dysfunction may therefore reduce the cardiovascular complications triggered by obesity. We tested the hypothesis that deficiency of P-selectin glycoprotein ligand-1 (Psgl-1) would improve the endothelial dysfunction associated with obesity. Psgl-1-deficient (Psgl-1(-/-)) and wild-type (Psgl-1(+/+)) mice were fed standard chow or a high-fat, high-sucrose diet (diet-induced obesity [DIO]) for 10 weeks. DIO increased mesenteric perivascular adipose tissue (mPVAT) macrophage content and vascular oxidative stress in Psgl-1(+/+) mice but not in Psgl-1(-/-) mice. Pressure myography using mesenteric arteries demonstrated that relaxation responses to acetylcholine were significantly impaired in DIO Psgl-1(+/+) mice, whereas DIO Psgl-1(-/-) mice were protected from endothelial dysfunction with similar relaxation responses to Psgl-1(+/+) or Psgl-1(-/-) mice fed standard chow. The superoxide scavenger 4-hydroxy-2,2,6,6-tetramethylpiperidinyloxy (TEMPOL) partially recovered impaired endothelial function induced by DIO. A neutralizing Psgl-1 antibody was also effective in preventing endothelial dysfunction and reducing mPVAT macrophage content induced by DIO. These results indicate that obesity in mice leads to PVAT inflammation and endothelial dysfunction that is prevented by Psgl-1 deficiency. Psgl-1 inhibition may be a useful treatment strategy for targeting vascular disease associated with obesity.
AuthorsHui Wang, Wei Luo, Jintao Wang, Chiao Guo, Xiaohong Wang, Stephanie L Wolffe, Peter F Bodary, Daniel T Eitzman
JournalDiabetes (Diabetes) Vol. 61 Issue 12 Pg. 3219-27 (Dec 2012) ISSN: 1939-327X [Electronic] United States
PMID22891216 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Antioxidants
  • Cyclic N-Oxides
  • Membrane Glycoproteins
  • P-selectin ligand protein
  • Spin Labels
  • tempol
Topics
  • Animals
  • Antioxidants (therapeutic use)
  • Cyclic N-Oxides (therapeutic use)
  • Endothelium, Vascular (drug effects, metabolism, physiopathology)
  • Immunoblotting
  • Immunohistochemistry
  • Male
  • Membrane Glycoproteins (therapeutic use)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Obesity (drug therapy, physiopathology)
  • Real-Time Polymerase Chain Reaction
  • Spin Labels
  • Vascular Diseases (metabolism, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: